Celldex Therapeutics, Inc. Message Board

Not all money is going to tech...just more money.

I also own other pharmas that are doing just fine, but they have steady icremental revenues growth each year...ALXN

Next 2-3 years will be finally good to us. The trifecta will start next year.

Zorbs,

Yes. The low price does not makes sense unless what someone posted about a week ago was true. Someone said shorting could be going on as a way to accumulate.

< Why would the banks park their money in CLDX in 2010 when they can double their money in tech. >

stockmage....

...so the FLOW OF MONEY in Bios is primarily Bank Driven iyo?

I can name several Bios up wildly this year w/ 0 dollars from the banks and their trusty hedge fund buddies!


so what do you do...over lay a bank/hedgy buyer screener as your last line of RISK mitigation?

frank

Its not the company or its potential.

Its about the flow of money. Its early and 2010 was a great year for my stocks, except CLDX. My Tech stocks profits increased 100-200% in one year due to increased demand, price stabilitization and years of cutting back employees.

Why would the banks park their money in CLDX in 2010 when they can double their money in tech. 2011 should be a better year for CLDX once other industries plateau and the market's tolerance for risk increases...that is no double dip recession.

weight, Starting to have my doubts...if its gonna be such a blockbuster then why are we trading at $4 with all those upgraded targets?

Zorbs, cdx-011 will be a blockbuster for melanoma and breast cancer.

http://www.indystar.com/article/20101214/BUSINESS03/12140311/1278/BUSINESS03/Eli-Lilly-shelves-trial-for-skin-cancer-drug

Thanks T, I think the end of day buying cheered me up. Celldex has a lot of potential with cdx-011 and cdx-110. More buying will happen in January as tax loss selling ends in about 15 days.

Don't worry, Weightbayou. We've all had our frustrations with this stock. But you know as well as anyone that we've hit our slow period when there's little news, awhile before our next update, and low volume means the stock slowly sinks.

But at the same time we are nearing the time when we will start to go back up. Partnerships will happen, but are not instantaneous and rarely happen in December. And once we have a timetable for CDX-110, that will help build the price support also.

Frank, IMGN has at least one cancer drug for breast cancer and CLDX has 2 or more drugs for breast cancer. Better times are ahead. Roche's loss is our gain is basically what you said earlier.